LGT Financial Advisors’s GSK GSK Stock Holding History

LGT Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-36	Closed	-$1.3K	–	902
2023 Q3	$1.3K	Buy	+36	New	+$1.28K	﹤0.01%	863

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LGT Financial Advisors's GSK Position: Q4 2023 in Review

LGT Financial Advisors sold out of GSK (GSK) in Q4 2023, closing a stake of 36 shares — an estimated $1.3K sold.

LGT Financial Advisors first reported a position in GSK in Q3 2023 and held it in 1 quarter. The position peaked at $1.3K in Q3 2023. 895 funds tracked by Wall St. Rank hold GSK as of Q4 2023.

LGT Financial Advisors reported no remaining GSK position as of Q4 2023 after selling out during the quarter.
LGT Financial Advisors sold 36 GSK shares in Q4 2023, an estimated $1.3K.
LGT Financial Advisors first reported a position in GSK in Q3 2023 and held it in 1 quarter.
LGT Financial Advisors's GSK position peaked at $1.3K in Q3 2023.
895 funds tracked by Wall St. Rank held GSK as of Q4 2023.

Based on LGT Financial Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.